3 Ways Combined DAM and MLR Drive Success in Roche, Merck KGaA, and LEO Pharma | Veeva
Summary
3 Ways Combined DAM and MLR Drive Success in Roche, Merck KGaA, and LEO Pharma The accelerated uptake in digital channels such as remote meetings and rep-triggered emails1 over the past few months compel life sciences companies to deliver more personalized and impactful content faster. Combining your medical, legal, review (MLR) process with your digital asset management (DAM) solution not only allows your company to adapt to these increasing demands for content but also streamlines workflows, maximizes its breadth, and addresses compliance. Here are three ways best-in-class life sciences companies benefit from a combined MLR and DAM solution: Roche’s merger with Genentech was the catalyst for a centralized content strategy model. Fabienne Vanderpoel, senior director of business optimization at Merck KGaA, Darmstadt, Germany, says, “With the right content journey, you can trace your material from global creation to local customer engagement. To achieve this, LEO Pharma built an integrated digital ecosystem to globally manage its content and engagement channels.
Classifications
AskAI Classifications
LabelsLinked Companies
